Skip to main content
Springer logoLink to Springer
. 2020 May 6;15(1):68. doi: 10.1007/s11657-020-00743-2

A surrogate FRAX model for the Kyrgyz Republic

O Lesnyak 1, A Zakroyeva 2, O Lobanchenko 3, H Johansson 4, E Liu 4, M Lorentzon 4,5, N C Harvey 6, E McCloskey 7, J A Kanis 4,7,
PMCID: PMC7203583  PMID: 32377964

Abstract

Summary

The hip fracture rates from Kazakhstan were used to create a surrogate FRAX® model for the Kyrgyz Republic.

Introduction

The International Society for Clinical Densitometry and International Osteoporosis Foundation recommend utilizing a surrogate FRAX model, based on the country-specific risk of death, and fracture data based on a country where fracture rates are considered to be representative of the index country.

Objective

This paper describes a surrogate FRAX model for the Kyrgyz Republic.

Methods

The FRAX model used the incidence of hip fracture from the neighbouring country of Kazakhstan and the death risk for the Kyrgyz Republic.

Results

Compared with the model for Kazakhstan, the surrogate model gave somewhat higher 10-year fracture probabilities for men between 60 and 80 years of age and lower probabilities for men above the age of 80. For women the probabilities were similar up to the age of 75–80 years and then lower. There were very close correlations in fracture probabilities between the surrogate and authentic models (1.00) so that the use of the Kyrgyz model had little impact on the rank order of risk. It was estimated that 2752 hip fractures arose in 2015 in individuals over the age of 50 years in the Kyrgyz Republic, with a predicted increase by 207% to 8435 in 2050.

Conclusion

The surrogate FRAX model for the Kyrgyz Republic provides the opportunity to determine fracture probability among the Kyrgyz population and help guide decisions about treatment.

Keywords: FRAX, Fracture probability, Epidemiology, Hip fracture, Kazakhstan, Surrogate, Kyrgyz Republic

Introduction

In 2008, the WHO Collaborating Centre for Metabolic Bone Diseases at the University of Sheffield, UK, developed algorithms to compute age-specific fracture probabilities in women and men from readily obtained clinical risk factors (CRFs) and BMD measurements at the femoral neck (http://www.shef.ac.uk/FRAX). The algorithm (FRAX®) was based on a series of meta-analyses using the primary data from population-based cohorts that identified several CRFs for fracture [1, 2]. FRAX models compute the probability of major osteoporotic fracture (hip, spine, distal forearm or proximal humerus) or hip fracture derived from the risk of fracture and the competing risk of death, both of which vary from country to country [3]. At present, FRAX models are available for 64 countries.

The availability of FRAX has stimulated studies that can be used for the generation of new FRAX models. Specific examples include Brazil, Mexico and Turkey [4]. The present study is a component part of the multicentre multinational population-based study in Eurasian countries (EVA study or ЭВА, in Russian). The broad aim of the study was to provide epidemiological information on fracture risk so that FRAX models could be created for Russia [5], Armenia [6], Belarus [7], Moldova [8], Kazakhstan [9], Uzbekistan and the Kyrgyz Republic. Ideally, data for both fracture incidence and death should be available for the construction of country-specific FRAX models. Unfortunately, the systems available to study the epidemiology of fracture proved to be inadequate in the Kyrgyz Republic.

Recognizing that data on hip and other fractures are not always available, the International Society for Clinical Densitometry and International Osteoporosis Foundation recommend using a surrogate FRAX model, based on the country-specific risk of death, and fracture data based on a country where fracture rates are considered to be representative of the index country [10]. Of the 66 countries for which a FRAX model is available, five FRAX country-specific models currently use surrogate data on fracture risk (Georgia, India, Palestine, Sri Lanka and Syria). The present report describes the development of a surrogate FRAX model for the Kyrgyz Republic.

Methods

The Kyrgyz Republic is a landlocked country with mountainous terrain. It is bordered by Kazakhstan to the north, Uzbekistan and Tajikistan to the southwest and China to the southeast. The Kyrgyz Republic has an area of 191,800 square kilometres (74,054 square miles) with a population estimated at 6,460,458 in 2019 [11]. The population of the Kyrgyz Republic is young with a median age of 25.3 years. Only 16.3% of the population has an age of 65 years or more.

Kazakhstan was chosen as a surrogate country for the Kyrgyz Republic FRAX model since the epidemiology of hip fracture in Kazakhstan was derived from the Almaty region, close to the Kyrgyzstan border. Details of the Kazakhstan FRAX model are available elsewhere [9]. Kazakhstan belongs to the moderate-risk countries for hip fracture for men and women [3]. National mortality rates for Kyrgyzstan used data from the World Health Organization for 2014 [12].

For the purpose of comparing the authentic FRAX model for Kazakhstan and the surrogate model for the Kyrgyz Republic, the probabilities of a major osteoporotic fracture (hip, clinical spine, forearm and humeral fractures) and of hip fracture alone were computed in men and women at ages 50, 60, 70 and 80 years for all possible combinations of clinical risk factors at BMD T-scores between 0 and − 3.5 SD in 0.5 SD steps with a BMI set to 26 kg/m2 [13]. Thus, we considered all combinations of six risk factors and eight values of BMD giving a total of 512 combinations. Note that this was not a population simulation, but an array of all possible combinations. The correlation between the probabilities derived from the surrogate and authentic models was examined by piecewise linear regression with knots at the probabilities of 40% for the Kazakhstan probabilities of a major osteoporotic fracture and hip fracture. Tabular data were used to compare probabilities between the two versions at the 50th (median) percentile of the distribution of the Kazakh model. Differences in the Kyrgyz model from the Kazakh model at these percentiles were expressed as 95% tolerance intervals (TI).

The age- and sex-specific incidence in 2015–2017 was applied to the Kyrgyz population in 2015 to estimate the number of hip fractures nationwide. Additionally, future projections were estimated up to 2050 assuming that the age- and sex-specific incidence remained stable. Population demography was taken from the United Nations using the medium variant for fertility [14].

Results

There was a close correlation between the FRAX model for Kazakhstan and the surrogate Kyrgyz model. In the case of women, the correlation coefficient was 1.0 with a slope of unity at all ages except for the age of 80 years. For men, the correlation coefficients were also high (r = 1.00), but the surrogate model gave somewhat higher probabilities than the Kazakh model at the age of 70 years. The relationship between the probabilities of a major osteoporotic fracture and hip fracture derived from the two versions of FRAX is shown for men and women age 70 years in Fig. 1. For men at the age of 70 years, the median value of the surrogate version was higher by about 12% for the probability of hip fracture and major osteoporotic fracture. At other ages, the difference was less than 3% (Table 1). For women the difference was less than 1% for ages below 80. For 80 years of age, the difference was 7%. Similarly, small and non-significant differences in fracture probabilities were noted at the 25th and 75th percentile of the probability distribution (data not shown).

Fig. 1.

Fig. 1

Comparison of 10-year probability of fracture using the surrogate FRAX tool for the Kyrgyz population and the Kazakh FRAX tool for multiple clinical scenarios at the age of 70 years. The left-hand panels show the comparison in men. The top panels relate to major osteoporotic fracture (MOF) and the lower panels to hip fracture probability. The diagonal line shows the line of identity

Table 1.

Probability (%) of a major osteoporotic fracture (MOF) or a hip fracture (with 95% tolerance intervals; TI) in men and women at the median of the probability distribution (Kazakh version) by age

Men Women
Kazakhstan Kyrgyz Republic Kazakhstan Kyrgyz Republic
Age Median Median 95% TI r value Median Median 95% TI r value
MOF
50 22.8 22.9 22.8–22.9 1.000 24.1 24.1 24.1–24.1 1.000
60 19.6 20.2 20.0–20.4 1.000 25.6 25.6 25.5–25.6 1.000
70 15.5 17.4 16.9–17.9 1.000 27.3 27.1 27.1–27.2 1.000
80 17.6 17.3 17.0–17.6 1.000 28.9 27.1 26.7–27.5 1.000
Hip fracture
50 6.9 6.9 6.9–7.0 1.000 4.8 4.8 4.8–4.8 1.000
60 6.8 7.0 6.9–7.2 1.000 6.0 6.0 6.0–6.0 1.000
70 8.3 9.4 9.0–9.8 1.000 10.7 10.6 10.6–10.7 1.000
80 12.2 11.9 11.6–12.2 1.000 16.8 15.7 15.4–16.0 1.000

Fracture projections

Assuming that the fracture rates in Kazakhstan were representative for the Kyrgyz Republic, and based on the UN estimates of the Kyrgyz population for 2015, we estimated that the annual number of hip fractures in men and women age 50 years or older in the Kyrgyz Republic in 2015 was 2752, comprising 984 in men and 1768 fractures in women. The number of major osteoporotic fractures was 9851 comprising 3756 in men and 6095 in women. The number of hip fractures is expected to increase progressively by calendar year with an increase of 207% by 2050 (Table 2). The increase in hip fracture numbers is particularly great in women (226% in women and 172% in men) due to the longer life expectancy in women.

Table 2.

Estimated total number of hip fractures (ICD-10 codes S72.0, S72.1, S72.2) in men and in women age 50 years and older in 2015 projected up to 2050 in the Kyrgyz Republic

2015 2020 2030 2040 2050
Men 984 1148 1496 2042 2672
Women 1768 1983 2795 4315 5763
Total 2752 3131 4291 6357 8435
Increase (%) 14 56 131 207

Discussion

The incidence of hip fracture in Kazakhstan was used to populate a surrogate FRAX model for the Kyrgyz Republic to compute the 10-year probabilities of hip and major osteoporotic fracture. In brief, the surrogate provided slightly higher estimates of fracture probability in men and similar or slightly lower estimates in women compared with the Kazakh model. The modest differences reflect the similarity in mortality between the two countries. Importantly, the differences had little impact on the categorization of risk, since there was little or no change in the rank order of fracture probability. In the clinical scenarios studied in this paper, the correlation coefficients between surrogate and Kazakh versions for fracture probability were 1.00, so that the one can be accurately predicted from the other. In other words, an individual at the 90th percentile of risk would still be at the 90th percentile of risk using the surrogate FRAX tool. Thus, any consequences of improving accuracy would reside in the absolute number generated and not in the rank order of risk. This is of little consequence to the management of patients or the interpretation of clinical studies. There is a useful analogy with the different DXA devices available, where a substantial difference in femoral neck BMD is seen between Hologic and Lunar machines, but the T-score derived from these is more or less identical [15]. However, marked difficulties arise when fracture probabilities are used in health economic analysis to inform practice guidelines.

There are obvious limitations to this study in that the assumption is that the fracture rates in the Kyrgyz Republic are similar to those in Kazakhstan. In addition to geographic proximity, peoples of Kazakhstan and Kyrgyzstan share several similarities. Kazakh and Kyrgyz nations are very close genetically [16]. Both countries have similar cultural and religious characteristics (prevailing religion, traditions, common Turkic language root) [17]. There is also commonality between the Almaty Region of Kazakhstan and Kyrgyzstan in major ethnic groups [18]. These observations do not test directly the similarity of fracture rates. Indeed, there are precedents for doubting the assumption, for example, the historical use of Romanian fracture rates to populate a surrogate Armenian model [6].

A minority of countries that have a FRAX model also have robust information on the risk of other major osteoporotic fractures. In the absence of such information, FRAX models are based on the assumption that the age- and sex-specific pattern of these fractures is similar to that observed in Malmo [19]. This assumption, used in the case of Kazakhstan, has been shown to be safe in studies reported from Canada [20], Iceland [21], USA [22], UK [23], Australia [24] and Moldova [8], despite differences in incidence between these countries [3]. This commonality of pattern is supported by register studies, which indicate that in those regions where hip fracture rates are high, so too is the risk of forearm fracture and spine fractures (requiring hospital admission) [25, 26].

The widespread availability of FRAX has resulted in its adoption in many practice guidelines worldwide [27]. The fracture probability equivalent to a woman with a prior fracture has been used as an intervention threshold in more than 30 countries. If the same threshold were applied to the Kyrgyz Republic, then intervention would be recommended with a probability of a major fracture that varied between 5.3 and 15% depending on age. The impact of such thresholds or alternative thresholds will require further study.

In summary, a surrogate FRAX model has been created for the Kyrgyz Republic. The model can provide the opportunity to determine fracture probability among the Kyrgyz population and help guide decisions about treatment.

Acknowledgements

The EVA project was supported by the International Osteoporosis Foundation (Epidemiology and quality of life working group). Servier, however, is acknowledged in helping with organization of the EVA project, ‘Epidemiology of osteoporotic fractures in Eurasian counties’ study (EVA or ЭВА, in Russian), of which this paper is one of the outcomes.

Compliance with ethical standards

Conflict of interest

O Lesnyak, A Zakroyeva, O Lobanchenko, H Johansson, E Liu, M Lorentzon, NC Harvey, E McCloskey and JA Kanis declare that they have no competing interests in relation to this paper. H Johansson, NC Harvey, E McCloskey and JA Kanis are the architects of FRAX in which they have no financial interest.

Ethical approval

All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or compatible ethical standards.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Kanis JA on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary healthcare level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK. Available at http://www.shef.ac.uk/FRAX/index.htm. Accessed 26 Feb 2012
  • 2.Kanis JA, Johnell O, Oden A, Johansson H, McCloskey EV. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–397. doi: 10.1007/s00198-007-0543-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl D, Cyrus Cooper C, on behalf of the IOF Working Group on Epidemiology and Quality of Life A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23:2239–2256. doi: 10.1007/s00198-012-1964-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kanis JA, Johansson H, Harvey NC, McCloskey EV. A brief history of FRAX. Arch Osteoporos. 2018;13:118. doi: 10.1007/s11657-018-0510-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lesnyak O, Ershova O, Belova K, Gladkova E, Sinitsina O, Ganert O, Romanova M, Khodirev V, Johansson H, McCloskey E, Kanis JA. Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Arch Osteoporos. 2012;7:67–73. doi: 10.1007/s11657-012-0082-3. [DOI] [PubMed] [Google Scholar]
  • 6.Lesnyak O, Sahakyan S, Zakroyeva A, Bilezikian JP, Hutchings N, Galstyan R, Lebedev A, Johansson H, Harvey NC, McCloskey E, Kanis JA. Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate. Arch Osteoporos. 2017;12(1):98. doi: 10.1007/s11657-017-0392-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ramanau H, Chernyanin I, Rudenka E, Lesnyak O, Zakroyeva A, Bilezikian JP, Johansson H, Harvey NC, McCloskey EV, Kanis JA. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models. Arch Osteoporos. 2018;13:42. doi: 10.1007/s11657-018-0454-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zakroyeva A, Lesnyak O, Cazac V, Groppa L, Russu E, Chislari L, Rotaru L, Johansson H, Harvey NC, McCloskey E, Kanis JA. Epidemiology of osteoporotic fracture in Moldova and development of a country specific FRAX model. Arch Osteoporos. 2020;15(1):13. doi: 10.1007/s11657-019-0669-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Issayeva S, Lesnyak O, Zakroyeva A, Issayeva B, Dilmanova D, Johansson H, NHarvey NC, McCloskey E, Kanis JA. Epidemiology of osteoporotic fractures in the Republic of Kazakhstan and the development of country specific FRAX model. Arch Osteoporos. 2020;15:30. doi: 10.1007/s11657-020-0701-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cauley JA, El-Hajj Fuleihan G, Arabi A, et al. Official positions for FRAX clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX_. J Clin Densitom. 2011;14(3):240e262. doi: 10.1016/j.jocd.2011.05.015. [DOI] [PubMed] [Google Scholar]
  • 11.United Nations (2017) Department of Economic and Social Affairs / population division. World Population Prospects https://wwwworldometersinfo/world-population/kyrgyzstan-population// Accessed 29 December 2019
  • 12.World Health Organization (2018) Health statistics and information systems: http://www.who.int/healthinfo/statistics/mortality_rawdata/en/ Accessed 17th June 2019
  • 13.Kanis JA, Johansson H, Oden A, Dawson-Hughes B, Melton LJ, 3rd, McCloskey EV. The effects of a FRAX((R)) revision for the USA. Osteoporos Int. 2010;21:35–40. doi: 10.1007/s00198-009-1033-8. [DOI] [PubMed] [Google Scholar]
  • 14.United Nations (2019) World population prospects 2019. Department of Economic and Social Affairs Population Dynamics https://populationunorg/wpp/Download/Standard/Population/ Accessed 4 Jan 2020
  • 15.Binkley N, Kiebzak GM, Michael Lewiecki EME, et al. Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence. J Bone Miner Res. 2005;20:195–201. doi: 10.1359/JBMR.041115. [DOI] [PubMed] [Google Scholar]
  • 16.Guo Y, Chen C, Jin X, et al. Autosomal DIPs for population genetic structure and differentiation analyses of Chinese Xinjiang Kyrgyz ethnic group. Sci Rep. 2018;8:11054. doi: 10.1038/s41598-018-29010-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pew Research Center (2009) Mapping the global Muslim population: a report on the size and distribution of the world's Muslim population. Available at: http://allafrica.com/download/resource/main/main/idatcs/00011909:cbf45d797f6515d212cec2ec5ef6fb5f.pdf, accessed 19th April 2020
  • 18.National Statistical Committee of the Kyrgyz Republic (2019) http://www.stat.kg/en/statistics/naselenie/ accessed 19th April 2020
  • 19.Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int. 2001;12:417–427. doi: 10.1007/s001980170112. [DOI] [PubMed] [Google Scholar]
  • 20.Lam A, LeslieWD LLM, Yogendran M, Morin SN, Majumdar SR. Major osteoporotic to hip fracture ratios in Canadian men and women with Swedish comparisons: a population-based analysis. J Bone Miner Res. 2014;29:1067–1073. doi: 10.1002/jbmr.2146. [DOI] [PubMed] [Google Scholar]
  • 21.Siggeirsdottir K, Aspelund T, Johansson H, Gudmundsson EF, Mogensen B, Jonsson BY, Gudnason V, McCloskey E, Oden A, Sigurdsson G, Kanis JA. The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX. Osteoporos Int. 2014;25:2445–2451. doi: 10.1007/s00198-014-2777-3. [DOI] [PubMed] [Google Scholar]
  • 22.Melton LJ, Crowson CS, O’Fallon WM. Fracture incidence in Olmsted County, Minnesota: comparison of urban and with rural rates and changes in urban rates over time. Osteoporos Int. 1999;9:29–37. doi: 10.1007/s001980050113. [DOI] [PubMed] [Google Scholar]
  • 23.Singer BR, McLauchlan CJ, Robinson CM, Christie J. Epidemiology of fracture in 15.000 adults. The influence of age and gender. J Bone Joint Surg. 1998;80B:234–238. doi: 10.1302/0301-620x.80b2.7762. [DOI] [PubMed] [Google Scholar]
  • 24.Sanders KM, Seeman E, Ugoni AM, Pasco JA, Martin TJ, Skoric B, Nicholson GC, Kotowicz MA. Age- and gender specific rate of fractures in Australia: a population-based study. Osteoporos Int. 1999;10(2):40–47. doi: 10.1007/s001980050222. [DOI] [PubMed] [Google Scholar]
  • 25.Johnell O, Gullberg B, Kanis JA. The hospital burden of vertebral fracture in Europe: a study of national register sources. Osteoporos Int. 1997;7:138–144. doi: 10.1007/BF01623689. [DOI] [PubMed] [Google Scholar]
  • 26.Melton LJ. Epidemiology of fractures. In: Riggs BL, Melton LJ, editors. Osteoporosis: etiology, diagnosis and management. 2. Philadelphia: Lippincott-Raven; 1995. pp. 225–227. [Google Scholar]
  • 27.Kanis JA, Harvey NC, Cyrus Cooper C, Johansson H, Odén A, McCloskey EV, the Advisory Board of the National Osteoporosis Guideline Group A systematic review of intervention thresholds based on FRAX. A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11:25. doi: 10.1007/s11657-016-0278-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Osteoporosis are provided here courtesy of Springer

RESOURCES